Table 2.
Clinical outcomes
| All patients (n (%)) |
NW | OW | O | p-value, overall | NW vs. OW | NW vs. O | OW vs. O | |
|---|---|---|---|---|---|---|---|---|
| Bleeding complications | ||||||||
| Life-threatening or major | 78 (14) | 35 (15) | 27 (14) | 16 (14) | 0.931 | 1.000 | 1.000 | 1.000 |
| Minor | 82 (15) | 31 (13) | 35 (18) | 16 (14) | 0.424 | 0.593 | 1.000 | 1.000 |
| Vascular complications | ||||||||
| Major | 76 (14) | 33 (14) | 27 (14) | 16 (14) | 0.980 | 1.000 | 1.000 | 1.000 |
| Minor | 74 (14) | 29 (12) | 30 (15) | 15 (13) | 0.701 | 1.000 | 1.000 | 1.000 |
| AKI stage ≥ 2 | 29 (5) | 18 (8) | 7 (4) | 4 (4) | 0.108 | 0.170 | 0.350 | 1.000 |
| PPI | 54 (10) | 24 (10) | 15 (8) | 15 (13) | 0.246 | 1.000 | 1.000 | 0.292 |
| New onset AF | 72 (13) | 34 (14) | 27 (14) | 11 (10) | 0.495 | 1.000 | 0.731 | 1.000 |
| TIA or stroke | 22 (4) | 8 (3) | 8 (4) | 6 (5) | 0.392 | 1.000 | 1.000 | 1.000 |
| POD | 77 (14) | 45 (19) | 19 (10) | 13 (12) | 0.012 | 0.013 | 0.189 | 1.000 |
| Infectiona | 38 (7) | 19 (8) | 13 (7) | 6 (5) | 0.631 | 1.000 | 1.000 | 1.000 |
| In-hospital stay, days | 6.7 ± 5.4 | 7.3 ± 6.3 | 6.1 ± 20 | 6.7 ± 5.8 | 0.057 | 0.050 | 1.000 | 0.864 |
| In-hospital mortality | 22 (4) | 12 (5) | 6 (3) | 4 (4) | 0.395 | 0.823 | 1.000 | 1.000 |
NW normal weight (18.5 ≤ BMI ≤ 24.9), OW overweight (25.0 ≤ BMI ≤ 29.9), O obese (BMI ≥ 30.0), AKI acute kidney injury, PPI permanent pacemaker implantation, AF atrial fibrillation, TIA transient ischaemic attack, POD postoperative delirium
aInfections (Urinary tract, OR access site, OR pneumonia, OR combined).